| Breast Primary | Lung Primary | ||
Tumor staging | Stage 0 | 22 (10%) | Stage I | 62 (29%) |
Stage I | 106 (49%) | Stage II | 29 (13%) | |
Stage II | 75 (35%) | Stage III | 44 (20%) | |
Stage III | 8 (4%) | Stage IV | 82 (38%) | |
Stage IV | 6 (2%) |
|
| |
Tumor subtypesa | IDC | 176 (81%) | Adenocarcinoma | 88 (41%) |
ILC | 15 (7%) | NSCLC NOS | 51 (24%) | |
DCIS | 21 (10%) | Squamous cell carcinoma | 34 (15%) | |
IDC/ILC (mammary) | 3 (1%) | Small cell lung cancer | 30 (14%) | |
Spindle Cell | 1 (0.5%) | Large cell lung cancer | 11 (5%) | |
Phyllodes | 1 (0.5%) | Carcinoid | 3 (1%) |